Kestra Medical (KMTS) CBO Timothy Moran Receives 39,113-Share Award

What Happened

• Timothy P. Moran, Chief Business Officer of Kestra Medical Technologies, was reported to have acquired 39,113 common shares under an award (Form 4 code "A"). The filing shows the shares were recorded at $0.00 on the Form 4 (acquisition type), reflecting an award/vesting rather than an open-market purchase.

Key Details

• Transaction date (reported): 2026-07-16 (Period of Report: 2026-07-15). Form filed: 2026-07-17.
• Transaction type/price: Award/Acquisition (A) — 39,113 shares at $0.00.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: These shares represent common shares earned from performance-based restricted stock units (PSUs) granted on July 17, 2025; 100% of the PSUs vested on July 15, 2026 (Footnote F1).
• Filing timeliness: The Form 4 was filed the day after the period date and appears timely based on provided dates.

Context

• This was a compensation-related award (performance RSUs) that vested based on company performance targets. Such grants are routine executive compensation and are recorded at $0 on Form 4 because no cash purchase was made. Awards differ from open-market purchases or sales and should be interpreted as part of pay/retention rather than a direct bullish or bearish trading signal.